Global Cell Counting Market is expected to grow at a CAGR of 6.9% during the forecast period 2020-2027
A new research report published by Fior Markets with the title Cell Counting Market by Product (Instruments, Consumables & Accessories), End-Use (Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Research Institutes, Contract Research Organizations, Other), Regions, and Global Forecast 2020-2027.
The global cell counting market is expected to grow from USD 9.73 billion in 2019 to USD 16.59 billion by 2027, at a CAGR of 6.9% during the forecast period 2020-2027.
The Asia-Pacific region is expected to grow at the highest CAGR during the forecast period 2020-2027. This growth is due to factors like growing investments by pharmaceutical & biotechnology companies, less complicated regulations, low development costs, the growing trend for research infrastructure modernization, vast genome pool, and rising number of stem cell, genomics, & proteomic research activities. On the other hand, the North America region accounted for the major market share of 39.9% in the year 2019, followed by Europe and is anticipated to grow throughout the projected period. The large share of this segment is attributed to key factors such as growing demand for early diagnosis of diseases along with effective treatment, increasing prevalence of chronic diseases, increasing focus on stem cell, biomedical, & cancer research, high incidence of target conditions, and rising demand for hi-tech instruments in research & diagnostic applications.
NOTE: Our analysts monitoring the situation across the globe explains that the market will generate remunerative prospects for producers post COVID-19 crisis. The report aims to provide an additional illustration of the latest scenario, economic slowdown, and COVID-19 impact on the overall industry.
DOWNLOAD FREE SAMPLE REPORT: https://www.fiormarkets.com/report-detail/418845/request-sample
Key players in the global cell counting market are Becton, Dickinson and Company, Tecan Trading AG, Danaher Corporation, Tip Biosystems, PerkinElmer Inc, Thermo Fisher Scientific Inc., Nexcelom Bioscience LLC, Corning Incorporated, Abbott, Siemens Healthcare Private Limited, Merck KGaA, Cole-Parmer Instrument Company LLC, Sysmex Corporation, Olympus Corporation, Logos Biosystems Inc, and Bio-Rad Laboratories, among others. Key companies are mainly focusing on developing new products, forming partnerships, and joint ventures to gain significant market share in the global cell counting market.
The product segment includes instruments and consumables & accessories. The automated cell counter segment, a sub-segment of the instruments segment is anticipated to grow at a high rate during the forecast period owing to their ability to quickly process large samples. The end-use segment includes hospitals & diagnostic laboratories, pharmaceutical & biotechnology companies, research institutes, contract research organizations, and other. Research institutes dominated the market and valued at USD 3.2 billion in the year 2019 owing to expanding pharmaceutical R&D expenditure and the rising number of regulatory approvals for cell culture-based vaccines.
About the report:
The global Cell Counting market is analyzed on the basis of value (USD Billion), volume (K Units), export (K Units), and import (K Units). All the segments have been analyzed on global, regional and country basis. The study includes an analysis of more than 30 countries for each segment. The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The study includes porter’s five forces model, attractiveness analysis, raw material analysis, and competitor position grid analysis.
Customization of the Report:
The report can be customized as per client requirements. For further queries, you can contact us on email@example.com or +1-201-465-4211. Our executives will be pleased to understand your requirements and offer you the best-suited reports.
- CDN Newswire